Implementation of pharmacogenomics into inpatient general medicine. Issue 2 (9th December 2022)

• Record Type: Journal Article
• Authors: Chen, Thomas; O'Donnell, Peter H.; Middlestadt, Merisa; Ruhnke, Gregory W.; Danahey, Keith; van Wijk, Xander M.R.; Choksi, Anish; Knoebel, Randall; Hartman, Seth; Yeo, Kiang-Teck Jerry; Friedman, Paula N.; Ratain, Mark J.; Nutescu, Edith A.; O'Leary, Kevin J.; Perera, Minoli A.; Meltzer, David O.
• Is Part Of: Pharmaocogenetics and genomics. Volume 33:Issue 2(2023)
• Page Start: 19
• Page End: 23
• Publication Date: 2022-12-09
• Subjects: implementation -- pharmacogenomics -- precision medicine; Pharmacogenetics -- Periodicals; Pharmacogenomics -- Periodicals; Genetic toxicology -- Periodicals; Biomedical genetics -- Periodicals; 615.7
• DOI: 10.1097/FPC.0000000000000487
• Languages: English
• ISSNs: 1744-6872

Abstract

Abstract : Pharmacogenomics is a crucial piece of personalized medicine. Preemptive pharmacogenomic testing is only used sparsely in the inpatient setting and there are few models to date for fostering the adoption of pharmacogenomic treatment in the inpatient setting. We created a multi-institutional project in Chicago to enable the translation of pharmacogenomics into inpatient practice. We are reporting our implementation process and barriers we encountered with solutions. This study, 'Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities', sought to implement pharmacogenomics into inpatient practice at three sites: The University of Chicago, Northwestern Memorial Hospital, and the University of Illinois at Chicago. This study involved enrolling African American adult patients for preemptive genotyping across a panel of actionable germline variants predicting drug response or toxicity risk. We report our approach to implementation and the barriers we encountered engaging hospitalists and general medical providers in the inpatient pharmacogenomic intervention. Our strategies included: a streamlined delivery system for pharmacogenomic information, attendance at hospital medicine section meetings, use of physician and pharmacist champions, focus on hospitalists' care and optimizing system function to fit their workflow, hand-offs, and dealing with hospitalists turnover. Our work provides insights into strategies for the initial engagement of inpatient general medicine providers that we hope will benefit other institutions seeking to implement pharmacogenomics in the inpatient setting.